Data / Form D filings / Anagin, Inc.
Anagin, Inc.: Form D filings
Anagin, Inc., a pharmaceuticals company in Indianapolis, IN, filed 3 Form D notices with the SEC between 2016 and 2018. The latest, on June 29, 2018, reports $1.3 million sold of a $1.4 million offering to 20 investors.
Find out what Anagin, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- INDIANA CTR FOR BIOMEDIC. INNOV. NOYES P, 5TH FLOOR, STE E504, 1800 N CAPITOL AVE., Indianapolis, IN, 46202
- Phone
- (317) 652-1840
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2013
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1679399
The full lists. Form D filings in Indiana: 436 rows, $21.80, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 29, 2018 | New notice | $1,400,000 | $1,308,688 | $91,312 | 20 | Jun 15, 2018 | sec.gov |
| Apr 25, 2017 | Amendment | $3,500,000 | $3,050,000 | $450,000 | 23 | Jun 30, 2016 | sec.gov |
| Jul 12, 2016 | New notice | $3,000,000 | $950,000 | $2,050,000 | 10 | Jun 30, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Anantha Shekhar | Director | |
| Derek Small | Director | |
| Frank French | Director | |
| Yvonne Lai | Executive Officer | |
| Jaswant Gidda | Executive Officer, Director | |
| James Schulz | Executive Officer | |
| Nora Doherty | Director |
Every Form D from the week of Jun 25, 2018 · All recent filings in Indiana · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Anagin, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.